Skip to main content
. 2018 Jan 6;2018:bcr2017222155. doi: 10.1136/bcr-2017-222155

Figure 4.

Figure 4

Evolution of LDL-C preapheresis, apoB preapheresis and LDL-C interapheresis values with different doses of lomitapide in patient 2. Aph, apheresis; ApoB, apolipoprotein B; LDL-C, low-density lipoprotein cholesterol; lomitapide doses are mg/day.